Overview

Study to Evaluate the Tolerance and Pharmacokinetics of Suramin Sodium

Status:
Unknown status

Trial end date:
2020-12-19

Target enrollment:

Participant gender:

Summary

This is a randomized, double-blind, placebo-controlled, single-dose with three incremental doses, Phase 1 study to evaluate the tolerance and pharmacokinetics of suramin sodium for injection in Chinese healthy adults.

Phase:

Phase 1

Details

Lead Sponsor:

First Affiliated Hospital of Zhejiang University

Collaborator:

Guangdong Kangda Pharmaceutical Co., Ltd

Treatments:

Suramin